Share on LinkedInShare on LinkedIn

ARTICLE · 24 MAY 2016

UPDATE: Subject Matter Eligibility Under 35 U.S.C. § 101 – Life Sciences

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Contributor
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private...

View firm profile
Explore more from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

The USPTO issued a memorandum on May 4, 2016 to the Patent Examining Corps to provide further Examiner instructions relating to subject matter eligibility under 35 U.S.C. § 101.

United StatesIntellectual Property

The United States Patent And Trademark Office (USPTO) issued a memorandum on May 4, 2016 (May 2016 Memo) to the Patent Examining Corps to provide further Examiner instructions relating to subject matter eligibility under 35 U.S.C. § 101. The memorandum addresses (1) how Examiners should formulate rejections under 35 U.S.C. § 101 and (2) how Examiners should evaluate applicant responses to rejections under 35 U.S.C. § 101. The May 2016 Memo provides additional instructions from the Interim Eligibility Guidance (2014) and the July 2015 Update. We previously posted synopses of the Interim Eligibility Guidance and the July 2015 Update.

This update focuses on how the May 2016 guidelines affect the patents and patent applications that relate to the life sciences. Mintz Levin has a separate update for how the May 2016 guidelines affect abstract ideas.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from